10月6日，诺诚健华盘中上涨5.01%，报14.04港元，成交额1631.85万港元。
生物科技板块整体回暖，康希诺生物涨13.03%，康方生物涨4.43%，三生制药涨2.83%，信达生物涨2.26%，百济神州涨0.46%，板块情绪回升带动个股反弹。
此前公司披露大股东Sunland BioMed Ltd减持500万股，持股比例由7.23%降至6.94%，该利空于前几个交易日已有所消化。公司与礼来达成的33.5亿美元研发合作及授权许可协议持续提供基本面支撑，市场关注度较高。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.